Thalia Therapeutics Plc (AIM:THAT)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 0.5750
0.00 (0.00%)
Nov 5, 2026, 10:15 AM GMT
Thalia Therapeutics Market Cap
Thalia Therapeutics has a market cap or net worth of 10.21 million as of November 5, 2026. It is the 39,709th most valuable company in the world and the 872nd biggest in the United Kingdom. Its market cap has increased by 104.47% in one year.
Market Cap
10.21M
Enterprise Value
8.71M
Revenue
7.22K
Global Rank
Country Rank
#872 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since May 3, 2017, Thalia Therapeutics's market cap has increased from 4.57M to 10.21M, an increase of 123.34%. That is a compound annual growth rate of 8.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 10.21M | 133.68% |
| Dec 31, 2025 | 4.37M | 110.82% |
| Dec 31, 2024 | 2.07M | -9.28% |
| Dec 29, 2023 | 2.28M | -47.18% |
| Dec 30, 2022 | 4.32M | -46.33% |
| Dec 31, 2021 | 8.06M | -46.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuPharma | 20.73M |
| SkinBioTherapeutics | 13.61M |
| Oxford BioDynamics | 13.44M |
| Genflow Biosciences | 10.34M |
| Aptamer Group | 9.85M |
| Fusion Antibodies | 7.51M |
| Palatin Technologies | 7.29M |
| CRISM Therapeutics | 6.77M |